Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




First Look at Key Viral Protein Could Improve Diagnosis of Autoimmune Diseases

By LabMedica International staff writers
Posted on 29 Aug 2025

Around 8% of the human genome comes from ancient viruses embedded during evolution, a part of the genome referred to as "dark matter. More...

" These viral remnants, called human endogenous retroviruses (HERVs), usually remain silent but can reawaken in disease states. They appear in certain cancers, autoimmune disorders, and neurodegenerative diseases. Scientists have now solved the first-ever 3D structure of a human HERV protein, offering a new pathway for diagnostics and therapies.

Researchers at the La Jolla Institute for Immunology (La Jolla, CA, USA) mapped the envelope glycoprotein (Env) of HERV-K, the most active retrovirus of its kind. Env proteins were historically impossible to study because of their instability, often unfolding before analysis. To preserve its natural shape, the team introduced stabilizing substitutions and used cryo-electron microscopy to capture the protein in its pre-fusion, infection-driving, and antibody-bound states.

The study, published in Science Advances, revealed that unlike HIV or SIV trimers, HERV-K Env has a tall, lean trimeric structure with a unique fold. This breakthrough marks a milestone in structural biology, as it is the first human HERV protein structure ever solved and only the third retroviral envelope structure solved overall. The team also developed antibodies to anchor the protein and visualize its various subunits, providing the first clear understanding of how immune responses target these molecules.

Importantly, HERV-K Env proteins appear on the surface of cancer cells—including breast and ovarian tumors—but not on healthy cells. This makes them an attractive target for cancer immunotherapies that can distinguish diseased from healthy tissue. Similarly, autoimmune patients like those with lupus or rheumatoid arthritis show aberrant HERV expression, suggesting the protein could serve as a diagnostic biomarker for immune-driven disease.

The discovery also provides insight into why immune cells sometimes mistakenly attack the body. The team demonstrated that their engineered antibodies could detect abnormal HERV expression on neutrophils in patient samples but not in healthy individuals. These findings highlight HERV-K Env’s potential as both a research tool and a clinical marker across oncology, immunology, and neurology.

“In many disease states, like autoimmune diseases and cancer, these genes re-awaken and start making pieces of these viruses,” said Erica Ollmann Saphire, Ph.D., MBA, President and CEO of the La Jolla Institute for Immunology. “Understanding the HERV-K Env structure, and the antibodies we now have, opens up diagnostic and treatment opportunities.”

Related Links:
La Jolla Institute for Immunology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.